HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

529.000

+39.2008.00%

Volume:45.41K

Turnover:23.13M

Market Cap:47.02B

PE:-630.49

High:540.000

Open:488.200

Low:463.000

Close:489.800

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:0.58

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:52.00

PE(LYR):-630.49

PS:219.85

Loading ...

Overview Company News Filings

DIAGENS-B (02526) Secures NMPA Class III Medical Device Registration for AI AutoVision®

Hangzhou Diagens Biotechnology Co Ltd - AI Autovision Receives Class Iii Medical Device Registration Certificate in China

THOMSON REUTERS

Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"

Stock Track | DIAGENS-B Soars 9.34% Intraday on Stellar 2025 Results and 331.7% Surge in Tech Licensing Revenue

DIAGENS-B Surges Over 9% in Late Trading Following Annual Tech Licensing Revenue Soaring 331.7%, Signaling Commercial Viability of Medical AI Model

Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report

DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair

Diagens Biotechnology's 2025 Loss Widens

MT Newswires Live

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

THOMSON REUTERS

杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万

Bulletin Express

Hangzhou Diagens publishes 2025 annual report

DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes

Bulletin Express

Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options

Hangzhou Diagens proposes articles of association amendments after Hong Kong listing

DIAGENS-B Proposes Implementation of Share Incentive Scheme

DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%

DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance

Bulletin Express

Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress

Diagens adopts full electronic dissemination of corporate communications

Bulletin Express

DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02526/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":529,"timestamp":1788163726622,"preClose":489.8,"halted":0,"volume":45405,"delay":0,"changeRate":0.08003266639444669,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Not Yet Opened","change":39.2,"latestTime":"08-31 16:08:46","open":488.2,"high":540,"low":463,"amount":23129735,"amplitude":0.157207,"askPrice":540,"askSize":150,"bidPrice":529,"bidSize":150,"shortable":0,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":489.8,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.5807231381918635,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":0.5807231381918635,"shares":88879200,"dividePrice":0,"high":540,"amplitude":0.157207,"preClose":489.8,"low":463,"week52Low":178,"pbRate":"52.00","psRate":"219.85","week52High":765.5,"institutionHeld":0,"latestPrice":529,"eps":-0.839024,"divideRate":0,"volume":45405,"delay":0,"ttmEps":-1.576,"open":488.2,"prevYearClose":99,"prevWeekClose":489.8,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":723,"twentyDayClose":387.4,"sixtyDayClose":320.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-08-28","current":-335.659898,"percent":0.861386,"low":-545.299386,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"high":-208.205701,"avg":-356.577672,"sd":65.687493,"marketCap":43533032160},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160}],"updateTime":1788211995173},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192558509","title":"DIAGENS-B (02526) Secures NMPA Class III Medical Device Registration for AI AutoVision®","url":"https://stock-news.laohu8.com/highlight/detail?id=1192558509","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192558509?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:36","pubTimestamp":1779438987,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) announced that on May 20, 2026, its core product AI AutoVision® has obtained a Class III Medical Device Registration Certificate issued by China's National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","CHAT","AGIX","159883","02526","AIPO","BK1100","09996","BK1574","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637949013","title":"Hangzhou Diagens Biotechnology Co Ltd - AI Autovision Receives Class Iii Medical Device Registration Certificate in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2637949013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637949013?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:30","pubTimestamp":1779438653,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100532115","title":"Registration Open for \"Zhihui Financial 2026 Summer Roadshow Conference\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1100532115","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100532115?lang=en_us&edition=fundamental","pubTime":"2026-05-18 10:47","pubTimestamp":1779072449,"startTime":"0","endTime":"0","summary":"In the first half of 2026, the Hong Kong capital market is experiencing a long-awaited period of heightened activity. Since the second quarter, the Hong Kong market has been on a sustained recovery...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0173614495.USD","BK1144","02659","LU1023057109.AUD","BK1162","LU0572940350.SGD","02652","BK1100","03881","02670","BK1161","BK1142","BK1594","01396","BK1147","BK1110","02729","02565","02411","02655","LU0359201612.USD","BK1539","LU0359201885.HKD","LU1224709979.USD","LU1328277881.USD","BK1171","BK1141","HK0001040143.USD","01300","BK1149","00400","08299","BK1229","LU0314109678.HKD","02142","00290","02706","BK1506","BK1163","LU0345781412.USD","BK1541","BK4588","LU1770034418.SGD","BK1583","BK1117","LU2039709279.SGD","LU0307460666.USD","LU1166156734.SGD","00305","BK1240","LU0630314457.HKD","06090","BK1191","02650","02889","LU0702159699.USD","LU1303224171.USD","BK1129","BK1205","BK1169","SG9999014674.SGD","01378","VXUS","01021","02228","01333","06051","BK1207","BK1592","BK1238","BK1198","01907","BK1249","LU0572939691.SGD","06636","LU1813983027.USD","BK1230","LU0287142896.SGD","LU0469268626.HKD","LU0359202008.SGD","06651","LU1719994722.HKD","02675","00363","03317","06682","BK1617","BK1183","00650","BK4585","LU0588546209.SGD","09696","BK1155","BK1258","02526","LU0737861699.HKD","LU1251922891.USD","BK1225","BK1116","LU0264606111.USD","00826","BK1109","BK1190","BK1500","LU0345780950.USD","BK1132","02685","06938","SG9999001093.SGD","02575","01384","03858","BK1613","02623","HK0001040168.HKD","BK1574","BK1578","BK1175","02726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115074411","title":"Stock Track | DIAGENS-B Soars 9.34% Intraday on Stellar 2025 Results and 331.7% Surge in Tech Licensing Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1115074411","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115074411?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:29","pubTimestamp":1778657369,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price soared 9.34% during the late trading session, following the release of the company's impressive 2025 annual performance report.The surge is attributed to the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181281095","title":"DIAGENS-B Surges Over 9% in Late Trading Following Annual Tech Licensing Revenue Soaring 331.7%, Signaling Commercial Viability of Medical AI Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1181281095","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181281095?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:28","pubTimestamp":1778657300,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) surged more than 9% in late trading. As of the latest update, the stock rose 9.01% to HK$326.8, with a turnover of HK$40,489,400. The company recently disclosed its 2025...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","VXUS","150261","02526","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197313481","title":"Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1197313481","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197313481?lang=en_us&edition=fundamental","pubTime":"2026-05-04 10:37","pubTimestamp":1777862241,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.The surge follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147735212","title":"DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair","url":"https://stock-news.laohu8.com/highlight/detail?id=1147735212","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147735212?lang=en_us&edition=fundamental","pubTime":"2026-05-04 10:35","pubTimestamp":1777862108,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","IPOS","BK4588","02251","BK1189","BK1100","02526","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631010495","title":"Diagens Biotechnology's 2025 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2631010495","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631010495?lang=en_us&edition=fundamental","pubTime":"2026-04-30 14:13","pubTimestamp":1777529604,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology  booked 67.1 million yuan in attributable loss for 2025, widening from a loss of 43.4 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.The medical imaging products maker's shares gained nearly 3% in afternoon trade Thursday.Loss per share was 0.84 yuan, compared with 0.55 yuan in 2024.Revenue more than doubled year on year to 164.4 million yuan from 70.4 million yuan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631050503","title":"Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine","url":"https://stock-news.laohu8.com/highlight/detail?id=2631050503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631050503?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:05","pubTimestamp":1777525504,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA6ZPDJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118483343","title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","url":"https://stock-news.laohu8.com/highlight/detail?id=1118483343","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118483343?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:30","pubTimestamp":1777476643,"startTime":"0","endTime":"0","summary":"杭州迪安剑生生物科技有限公司在本年度报告中披露，2025年度集团整体业务保持快速增长，营业收入达到人民币1.64424亿元（下同，金额均以“亿元”计，下同，数据来自原报告记载的“百万元”除以100换算），较2024年度的0.70352亿元同比增长约133.6%。毛利约为1.18087亿元，较上年同期的0.46061亿元增长超过一倍，毛利率升至71.8%。值得注意的是，技术授权收入约0.84300亿...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631439945","title":"Hangzhou Diagens publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631439945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631439945?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:30","pubTimestamp":1777473033,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology annual report for year ended Dec. 31, 2025 flagged a shift from product-led sales toward platform-driven monetization, with technology licensing becoming largest revenue stream at RMB 84.34 million.Core chromosome karyotyping software AI AutoVision was designated a Class III Innovative Medical Device in May 2025, with China NMPA registration still under review and targeted for completion in Q2 2026.iMedImage foundation model scaled to 104 billion parameters, positioning business to expand beyond single-disease tools into broader medical imaging workflows.iMed MaaS platform launched March 31, 2025, with six-month rollout cited at 65 hospital partnerships and 92 imaging-focused models incubated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1TGvcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181077977","title":"DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1181077977","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181077977?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:06","pubTimestamp":1777453603,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced a plan to revise its Articles of Association following two significant developments: the March 2025 update of the China Securities...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631981845","title":"Hangzhou Diagens proposes share incentive scheme featuring RSUs and stock options","url":"https://stock-news.laohu8.com/highlight/detail?id=2631981845","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631981845?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:01","pubTimestamp":1777453281,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed adoption of a share incentive scheme covering restricted share units and options.Board resolution dated April 29, 2026 set up shareholder vote at an AGM or EGM targeted for around June 2026.Awards would be settled using H shares bought in secondary market, newly issued H shares, or treasury shares.Company plans to publish a circular with meeting notice and scheme details.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3G234w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631904598","title":"Hangzhou Diagens proposes articles of association amendments after Hong Kong listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631904598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631904598?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:00","pubTimestamp":1777453243,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology proposed amendments to its articles of association, following regulatory updates and its March 30, 2026 Main Board listing in Hong Kong.Changes aim to align governance documents with updated PRC rules issued in March 2025.Revisions also reflect a post-IPO share capital structure of 88,879,200 shares, all H shares.Amendments require shareholder approval via special resolution at upcoming annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL6FGGzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129004203","title":"DIAGENS-B Proposes Implementation of Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004203","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129004203?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:52","pubTimestamp":1777452764,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) has announced that its board of directors passed a resolution during a meeting held on April 29, 2026, recommending the adoption of a share incentive plan. The plan aims to foster...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100","BK0251","301122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165416316","title":"DIAGENS-B Showcases Medical Imaging Base Model Capable of Slashing AI Development Costs by Over 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165416316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165416316?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:31","pubTimestamp":1776861069,"startTime":"0","endTime":"0","summary":"At the recent 2026 10th Everything Grows Conference, Hangzhou DIAGENS Biotechnology Co., Ltd. presented its self-developed iMedImage® medical imaging base model in the \"Hangzhou AI 18 Arhats\" joint...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","AIPO","ARTY","BK1100","AGIX","BK1189","02251","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175371587","title":"DIAGENS-B March 2026 Monthly Return Shows Stable Share Base and Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175371587","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175371587?lang=en_us&edition=fundamental","pubTime":"2026-04-22 17:08","pubTimestamp":1776848882,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) filed a resubmitted monthly return with Hong Kong Exchanges and Clearing on 22 April 2026, covering the period to 31 March 2026—the company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139693430","title":"Stock Track | DIAGENS-B Soars 5.41% Intraday on Strong Q1 Earnings and AI Product Regulatory Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1139693430","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139693430?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823280,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price surged 5.41% during intraday trading on Wednesday, extending its recent positive momentum in the market.The significant upward movement appears driven by a combination of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187377963","title":"Diagens adopts full electronic dissemination of corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1187377963","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187377963?lang=en_us&edition=fundamental","pubTime":"2026-04-20 16:43","pubTimestamp":1776674625,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) announced that, in line with Rule 2.07 of the Hong Kong Stock Exchange Listing Rules and the paperless listing regime effective since 31 December...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127375670","title":"DIAGENS-B Shares Surge Over 7% Again, AI AutoVision Nears Approval as First Domestic AI-Powered Chromosome Analysis Diagnostic Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=1127375670","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127375670?lang=en_us&edition=fundamental","pubTime":"2026-04-20 10:30","pubTimestamp":1776652234,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) saw its shares rise more than 7% again. As of the time of writing, the stock was up 6.02%, trading at HKD 299.2 with a turnover of HKD 27.43 million. Public information indicates...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK4585","AIPO","ARTY","BK1100","AGIX","VGT","VXUS","BK4588","159180","CHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":88,"code":"91000000","status":"200"}]}}